Community Health Workers and mHealth for HIV/AIDS
(CHAMPS+ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve the health of people with HIV in Alabama, Louisiana, and Mississippi. It tests a new approach using mobile health technology and community health workers to help participants adhere to their medication and reduce the virus in their blood. The study compares usual health services with an experimental group that receives special pill bottles, counseling sessions (CHW Sessions), and tools to track medication and health. Ideal candidates for this trial are individuals living with HIV who have a detectable viral load, own a smartphone, and reside in one of the three states mentioned. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance HIV care and management.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study focuses on improving ART adherence, it's likely that you will continue your current HIV medications.
What prior data suggests that the CHAMPS+ intervention is safe for participants?
Research shows that using community health workers (CHWs) in healthcare is generally safe and well-received. Studies indicate that CHWs can effectively help people with HIV adhere to their antiretroviral therapy (ART), which is essential for maintaining health and preventing virus transmission.
A review of various studies found that CHW programs often lead to better health outcomes without major safety issues. These workers receive training to provide education, support, and connections to healthcare services. This approach has successfully improved health without significant side effects or risks to participants.
While research on CHW programs is encouraging, these findings pertain to the general safety and effectiveness of CHW support. Individual experiences may vary, so discussing any concerns with healthcare providers is always advisable.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it combines innovative technology with personalized support to improve HIV/AIDS management. The intervention uses the CleverCap pill bottle, which ensures patients take the correct dosage by dispensing only the prescribed amount and wirelessly tracking medication use. This is paired with mHealth integration through the WiseApp, allowing for seamless communication and monitoring. Additionally, participants receive 10-12 sessions with Community Health Workers (CHWs), offering tailored guidance and support. This approach aims to enhance adherence to medication and promote better health outcomes compared to standard care options.
What evidence suggests that the CHAMPS+ intervention could be effective for improving ART adherence and viral suppression in people with HIV?
In this trial, participants will be divided into groups to assess the impact of community health workers (CHWs) and mobile health (mHealth) tools on health outcomes for people with HIV/AIDS. Studies have shown that CHWs can significantly improve health outcomes by helping individuals adhere to their antiretroviral therapy (ART), which is crucial for controlling the virus. One study found that adding CHWs to HIV care teams led to better care and increased viral suppression, making the virus undetectable in the blood. Participants in the intervention group will receive sessions with CHWs and use mHealth tools, such as special pill bottles that monitor medication use, which have shown promise in aiding patients to take their medications as prescribed. By addressing issues like distrust in the health system and stigma, CHWs, along with mHealth technology, offer a supportive approach to improving treatment outcomes for people with HIV.34678
Who Is on the Research Team?
Rebecca Schnall, PhD, MPH
Principal Investigator
Columbia University
Scott Batey, PhD, MSW
Principal Investigator
Tulane University
Are You a Good Fit for This Trial?
The CHAMPS+ trial is for people living with HIV/AIDS in the Deep South of the US who are struggling with ART adherence and viral suppression. Participants should be willing to use mHealth technology and work with community health workers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the CHAMPS+ intervention, including the CleverCap pill bottle and 10-12 sessions with community health workers
Follow-up
Participants are monitored for ART adherence and viral load suppression
What Are the Treatments Tested in This Trial?
Interventions
- CHW Sessions
CHW Sessions is already approved in United States for the following indications:
- Improving ART adherence and viral suppression among people with HIV
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
Tulane University
Collaborator
University of Alabama at Birmingham
Collaborator
Unity Wellness Center
Collaborator
Louisiana State University Health Sciences Center in New Orleans
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
University of Mississippi Medical Center
Collaborator
Health Services Center, Inc.
Collaborator